The biotech industry is on track to raise $44 billion in 2011—the most ever, including the genomics bubble of 2000. Biotech indexes performed well and the private biotech sector was also up, raising $2.9 billion. Excluding partnership monies, biotechs pulled in $22.1 billion during the first six months; debt deals accounted for more than two-thirds of the total. Initial public offerings remained sluggish, with only 11 companies raising $514.2 million altogether.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yang, W. Biotech on pace for record year. Nat Biotechnol 29, 780 (2011). https://doi.org/10.1038/nbt.1970
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1970
